Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polyphyllin D Shows Anticancer Effect through a Selective Inhibition of Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP2). | Molecules | 2021 | 33562835 | PubTator, text mining | PubMed |
| CD200:CD200R Interactions and Their Importance in Immunoregulation. | Int J Mol Sci | 2021 | 33562512 | PubTator, text mining | PubMed |
| Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway. | Food Chem Toxicol | 2021 | 33561516 | PubTator, text mining | PubMed |
| Sperm DNA methylation mediates the association of male age on reproductive outcomes among couples undergoing infertility treatment. | Sci Rep | 2021 | 33547328 | PubTator, text mining | PubMed |
| microRNA let-7i-5p mediates the relationship between muscle fat infiltration and neck pain disability following motor vehicle collision: a preliminary study. | Sci Rep | 2021 | 33542428 | PubTator, text mining | PubMed |
| Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway. | Cell Rep | 2021 | 33535033 | PubTator, text mining | PubMed |
| A Peptide-Nucleic Acid Targeting miR-335-5p Enhances Expression of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene with the Possible Involvement of the CFTR Scaffolding Protein NHERF1. | Biomedicines | 2021 | 33530577 | PubTator, text mining | PubMed |
| Serum microRNAs as Tool to Predict Early Response to Benralizumab in Severe Eosinophilic Asthma. | J Pers Med | 2021 | 33525548 | PubTator, text mining | PubMed |
| Plexin-B2 facilitates glioblastoma infiltration by modulating cell biomechanics. | Commun Biol | 2021 | 33514835 | PubTator, text mining | PubMed |
| Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma. | PeerJ | 2021 | 33510968 | PubTator, text mining | PubMed |
| Therapeutic Implications of Detecting MAPK-Activating Alterations in Cutaneous and Unknown Primary Melanomas. | Clin Cancer Res | 2021 | 33509808 | PubTator, text mining | PubMed |
| Analyzing the G3BP-like gene family of Arabidopsis thaliana in early turnip mosaic virus infection. | Sci Rep | 2021 | 33500425 | PubTator, text mining | PubMed |
| Loss-of-function variants in SEMA3F and PLXNA3 encoding semaphorin-3F and its receptor plexin-A3 respectively cause idiopathic hypogonadotropic hypogonadism. | Genet Med | 2021 | 33495532 | PubTator, text mining | PubMed |
| Systemic and CNS manifestations of inherited cerebrovascular malformations. | Clin Imaging | 2021 | 33493737 | PubTator, text mining | PubMed |
| Chiari I malformation with Klippel-Trenaunay syndrome: case report and review of the literature. | Childs Nerv Syst | 2021 | 33492467 | PubTator, text mining | PubMed |
| Managing Vascular Anomalies in the Era of Genetics and Precision Medicine: An Opportunity or a Challenge? | Ann Plast Surg | 2021 | 33470620 | PubTator, text mining | PubMed |
| Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling. | Int J Mol Sci | 2021 | 33467535 | PubTator, text mining | PubMed |
| Genetic engineering in organoids. | J Mol Med (Berl) | 2021 | 33459801 | PubTator, text mining | PubMed |
| Combined SHPments: An Effective Therapeutic Strategy for MPNST. | Cancer Res | 2021 | 33452215 | PubTator, text mining | PubMed |
Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer. | Molecules | 2021 | 33440689 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=55